ArticleInternational urogynecology journal2026
Effectiveness of High-Intensity Focused Electromagnetic (HIFEM) Therapy in Women with Urinary Incontinence.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of High-Intensity Electromagnetic Therapy and Pelvic Floor Muscle Exercises in Women with Urinary Incontinence: A Randomized Controlled Trial.International journal of women's health · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisUrinary incontinence (UI) affects the quality of life of millions of women. High-intensity focused electromagnetic (HIFEM) therapy is a promising noninvasive treatment, but robust evidence is limited. This study aimed to evaluate the effectiveness of HIFEM therapy in improving UI symptoms, quality of life, and sexual function in Thai women.
methodsThis prospective single-arm interventional study enrolled women aged ≥ 20 years with an International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score ≥ 6. Women with pelvic organ prolapse stage > 2 or with contraindications to HIFEM therapy were excluded. Participants received six HIFEM sessions over 3 weeks. Outcomes, including the ICIQ-UI SF, Incontinence Impact Questionnaire (IIQ-7), and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR), were assessed at baseline, post-treatment, and 3-month follow-up. Generalised estimating equations, mean/median difference (MD) with 95% confidence intervals (CI), were used for statistical analysis.
resultsFifty-seven women completed the protocol. UI types were stress UI (43.9%), mixed UI (42.1%), and urgency UI (14.0%). Median ICIQ-UI SF significantly decreased at post-treatment (MD -5.21; 95% CI -6.23 to -4.19) and 3 months (MD -5.04; 95% CI -6.13 to -3.94; p < 0.001). IIQ-7 scores improved similarly. Among sexually active women, improvements were noted in arousal/orgasm, and condition impact subscales of PISQ-IR. No significant changes were found in non-sexually active women.
conclusionsHIFEM therapy significantly improved UI symptoms, quality of life, and some aspects of sexual function. Larger comparative trials with long-term follow-up are needed before routine clinical use is recommended.
Indexed as
Identifiers
41051574What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.